(PDF) P2.01-21 Antigen Cascade Triggering Correlates With

P2.01-21 Antigen Cascade Triggering Correlates With Prolonged Survival in Advanced NSCLC Patients Undergone PD-1 Blockade With Nivolumab.

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.1075

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

PD-1 Blockade With Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

New England Journal of Medicine

English

P2.01-61 Body Mass Index Over Time Is Associated With Overall Survival in Advanced NSCLC Patients Treated With Immunotherapy.

Journal of Thoracic Oncology

Respiratory Medicine

English

Nivolumab Improves Survival for Patients With Advanced Lung Cancer

Cancer Research

English

Predictive Factors Associated With Prolonged Survival in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated With Gefitinib

British Journal of Cancer

Cancer Research

English

P1.01-18 Immunosenescence Correlates With Progression Upon PD-(L)-1 Blockade (IO) in Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-44 CYFRA 21-1 as a Predictor to Response to Chemotherapy and Overall Survival in Patients With Advanced NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma

Journal of Thoracic Oncology

Respiratory Medicine

English

P023 Factors Associated With Administration of Subsequent Cytotoxic Chemotherapy After Nivolumab in Patients With Advanced NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-06 HSP72 Expression Associates With Survival in EGFR Mutated NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English